Medical Research
(H30Z)
IRS Verified
DX Registered
990 on File
MAINE CANCER FOUNDATION
Financial strength (30%)
69/100
Reliability (20%)
55/100
Effectiveness (25%)
86/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
Maine Cancer Foundation (MCF) is dedicated to reducing cancer incidence and mortality rates in Maine. 100% of the funds we raise are invested back into our communities to benefit the people of Maine.
Financial Overview — FY 2025
$3.6M
Total Revenue
$3.8M
Total Expenses
$5.6M
Net Assets
8
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
88.3%
Fundraising Efficiency
105.4%
Operating Reserve
17.83x
Liability-to-Asset
21.0%
Revenue Diversification
86.9%
Executive Compensation
$236K
Compared with Peers
FY 2025
Compared with 132 similar organizations
(United States, Medical Research, $1M–$10M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
88.3% | 83.0% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
3.5% | 9.9% |
P10P90
|
Top quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
8.2% | 2.6% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
105.4% | 110.6% |
P10P90
|
Above median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
17.8 mo | 14.4 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
21.0% | 13.2% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
86.9% | 90.0% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
-6.2% | 7.4% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
0.8% | 3.0% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-5.1% | 4.8% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $3.6M | $3.8M | $5.6M | 88.3% | 8 |
| 2024 | $3.8M | $3.7M | $5.8M | 88.9% | 7 |
| 2023 | $3.3M | $3.2M | $5.6M | 88.7% | 7 |
| 2022 | $2.9M | $3.2M | $5.4M | 90.2% | 7 |
| 2021 | $2.3M | $2.6M | N/A | — | 8 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.